1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity

Detalles Bibliográficos
Autores principales: Obermannova, R., Demlova, R., Selingerova, I., Doubek, M., Okrouhlicova, D., Mlnarikova, M., Pilatova, K., Nevrlka, J., Lejdarova, H., Weinbergerova, B., Cermakova, Z., Valik, D., Mayer, J., Kiss, I., Zdrazilova-Dubska, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454423/
http://dx.doi.org/10.1016/j.annonc.2021.08.1556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454423/
http://dx.doi.org/10.1016/j.annonc.2021.08.1556

Ejemplares similares